Lower close after Flynn pleads guilty


The markets closed lower with the Dow falling 40 points to 24,231 after former national security advisor Michael Flynn pleaded guilty to lying to the FBI. Nasdaq lost 26 points to 6,847.

On the upside

American Woodmark (Nasdaq: AMWD) reported higher second quarter earnings and revenue and announced plans to acquire RSI Home Products for approximately $486 million in cash and stock.

The Food and Drug Administration approved Foundation Medicine's (Nasdaq: FMI) FoundationOne CDx diagnostic test for solid tumors.

Bargain hunters lifted shares of Stitch Fix (Nasdaq: SFIX). 

On the downside 

Genesco (NYSE: GCO) fell to a greater than expected loss for the third quarter.

Zumiez (Nasdaq: ZUMZ) reported higher third quarter earnings and revenue but the company forecast slowing growth in the fourth quarter. 

The underwriters of Sogou's (NYSE: SOGO) initial public offering have exercised their over allotment option.

In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners outpaced advancers by a margin of more than 3 to 2 on Nasdaq. The broader S&P 500 lost 5 points to 2,642. Bitcoin rocketed $998 to $10,848.

About this Entry

This page contains a single entry by published on December 1, 2017 2:18 PM.

Amazon explores drug purchasing was the previous entry in this blog.

Markets surge on passage of Senate tax bill is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12